# An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

> **NCT00784875** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 643 (actual)

## Conditions studied

- Primary Insomnia
- Secondary Insomnia

## Interventions

- **DRUG:** LY2624803
- **DRUG:** LY2624803
- **DRUG:** Placebo
- **DRUG:** zolpidem

## Key facts

- **NCT ID:** NCT00784875
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 643 (ACTUAL)
- **Last updated:** 2012-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784875, "An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00784875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*